These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 22121251)

  • 21. Parkinsonism in multiple system atrophy: natural history, severity (UPDRS-III), and disability assessment compared with Parkinson's disease.
    Tison F; Yekhlef F; Chrysostome V; Balestre E; Quinn NP; Poewe W; Wenning GK
    Mov Disord; 2002 Jul; 17(4):701-9. PubMed ID: 12210859
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vascular Parkinsonism and cognitive impairment: literature review, Brazilian studies and case vignettes.
    Vale TC; Barbosa MT; Caramelli P; Cardoso F
    Dement Neuropsychol; 2012; 6(3):137-144. PubMed ID: 29213787
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Rehabilitation of gait disorders in patients with Parkinson's disease and vascular parkinsonism].
    Pokhabov DV; Abramov VG; Nesterova IuV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(2):20-5. PubMed ID: 19365367
    [TBL] [Abstract][Full Text] [Related]  

  • 24. "Pure" striatonigral degeneration and Parkinson's disease: a comparative clinical study.
    Gouider-Khouja N; Vidailhet M; Bonnet AM; Pichon J; Agid Y
    Mov Disord; 1995 May; 10(3):288-94. PubMed ID: 7651445
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The diagnosis of manganese-induced parkinsonism.
    Cersosimo MG; Koller WC
    Neurotoxicology; 2006 May; 27(3):340-6. PubMed ID: 16325915
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Vascular parkinsonism].
    Zhuchenko TD; Veĭn AM; Golubev VL; Shtul'man DR; Shvareva IS
    Zh Nevrol Psikhiatr Im S S Korsakova; 1998; 98(4):62-5. PubMed ID: 9606903
    [No Abstract]   [Full Text] [Related]  

  • 27. Vascular parkinsonism--an important update.
    Turnbull C
    Age Ageing; 2005 Mar; 34(2):97-8. PubMed ID: 15713851
    [No Abstract]   [Full Text] [Related]  

  • 28. Neuroleptic-induced parkinsonism and Parkinson's disease: differential diagnosis and treatment.
    Hausner RS
    J Clin Psychiatry; 1983 Jan; 44(1):13-6. PubMed ID: 6130081
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Three-dimensional gait biomechanics in Parkinson's disease: evidence for a centrally mediated amplitude regulation disorder.
    Morris M; Iansek R; McGinley J; Matyas T; Huxham F
    Mov Disord; 2005 Jan; 20(1):40-50. PubMed ID: 15390033
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Parkinsonian syndromes associated with hydrocephalus: case reports, a review of the literature, and pathophysiological hypotheses.
    Curran T; Lang AE
    Mov Disord; 1994 Sep; 9(5):508-20. PubMed ID: 7990846
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Gait disorders in Parkinson's disease: and pathophysiological approaches].
    Moreau C; Cantiniaux S; Delval A; Defebvre L; Azulay JP
    Rev Neurol (Paris); 2010 Feb; 166(2):158-67. PubMed ID: 19616816
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Early diagnosis of Parkinson's disease: recommendations from diagnostic clinical guidelines.
    Pahwa R; Lyons KE
    Am J Manag Care; 2010 Mar; 16 Suppl Implications():S94-9. PubMed ID: 20297872
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vascular parkinsonism--characteristics, pathogenesis and treatment.
    Korczyn AD
    Nat Rev Neurol; 2015 Jun; 11(6):319-26. PubMed ID: 25917706
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gait stride-to-stride variability and foot clearance pattern analysis in Idiopathic Parkinson's Disease and Vascular Parkinsonism.
    Ferreira F; Gago MF; Bicho E; Carvalho C; Mollaei N; Rodrigues L; Sousa N; Rodrigues PP; Ferreira C; Gama J
    J Biomech; 2019 Jul; 92():98-104. PubMed ID: 31182234
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Vascular Parkinson syndromes: a controversial concept].
    Fénelon G; Houéto JL
    Rev Neurol (Paris); 1998 May; 154(4):291-302. PubMed ID: 9773057
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Vascular parkinsonism].
    Yamanouchi H
    Nihon Rinsho; 1997 Jan; 55(1):106-11. PubMed ID: 9014431
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Cerebrovascular parkinsonism--clinicopathologic study].
    Yamanouchi H; Nagura H
    Rinsho Shinkeigaku; 1995 Dec; 35(12):1457-8. PubMed ID: 8752429
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neurological signs and frontal white matter lesions in vascular parkinsonism. A clinicopathologic study.
    Yamanouchi H; Nagura H
    Stroke; 1997 May; 28(5):965-9. PubMed ID: 9158634
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vascular parkinsonism: a clinical review.
    Benamer HT; Grosset DG
    Eur Neurol; 2009; 61(1):11-5. PubMed ID: 18948694
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Pharmacological hypotheses and therapeutic strategies for gait disorders in Parkinson's disease].
    Devos D; Bordet R; Defebvre L
    Rev Neurol (Paris); 2010 Feb; 166(2):168-77. PubMed ID: 19811797
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.